Targeting ER-Positive/HER2-Negative Breast Cancer: Clinical Application of New Advances in Community Practice

Download a slideset on managing early- and advanced-stage ER-positive HER2-negative breast cancer and toxicities associated with targeted therapies.

Share

Program Content

AEs With Oral Therapies
Managing Adverse Events and Strategies for Promoting Adherence to Oral CDK4/6 and PI3K Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2022

Expires: July 25, 2023

View Activity
Therapy for HR+/HER2- BC
Selection and Sequencing of Targeted Therapy for HR+/HER2- Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: July 26, 2022

Expires: July 25, 2023

View Activity

Faculty

cover img faculity

Jamie Carroll, MSN, CNP, APRN

Instructor, Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Sanofi Genzyme